摘要:
The present invention relates to a developing apparatus which has a developer container, a developer bearing member and a developer sealing member. Also, it is mainly featured that at least a part of the developer sealing member is a conductive portion, and the developer bearing member and the conductive portion have a same potential when a voltage is applied to the developer bearing member.
摘要:
A developing device includes a developing container for accommodating a developer; a developer carrying member, disposed in an opening of the developing container, for carrying a developer; a developer charging member for being contacted to the developer on the developer carrying member and supplied with a voltage of the same polarity as the developer and not less than a discharge start voltage.
摘要:
An image forming apparatus includes an image bearing member, a charging rotary member rotating while contacting with the image bearing member, and a slide friction sheet contacting with the charging rotary member along an axial direction of the charging rotary member for dispersing contamination adhered to the charging rotary member.
摘要:
Provided is a novel therapeutic agent specific for a malignant tumor expressing MHC class II. The present invention provides an antibody recognizing a protein constituting MHC class II expressed on a malignant tumor, the antibody comprising at least one selected from heavy chain CDR1 (amino acid sequence represented by positions 49 to 54 of SEQ ID NO: 54), heavy chain CDR2 (amino acid sequence represented by positions 69 to 84 of SEQ ID NO: 54), heavy chain CDR3 (amino acid sequence represented by positions 117 to 128 of SEQ ID NO: 54), light chain CDR1 (amino acid sequence represented by positions 46 to 55 of SEQ ID NO: 56), light chain CDR2 (amino acid sequence represented by positions 71 to 77 of SEQ ID NO: 56), and light chain CDR3 (amino acid sequence represented by positions 100 to 108 of SEQ ID NO: 56).
摘要翻译:提供一种特异于表达II类MHC的恶性肿瘤的新型治疗剂。 本发明提供一种抗体,其识别构成在恶性肿瘤上表达的II类MHC的蛋白质,所述抗体包含选自重链CDR1(SEQ ID NO:54的49至54位的氨基酸序列)中的至少一种,重链 CDR2(SEQ ID NO:54的第69〜84位的氨基酸序列),重链CDR3(SEQ ID NO:54的117〜128位的氨基酸序列),轻链CDR1(由位置 SEQ ID NO:56的46〜55),轻链CDR2(由SEQ ID NO:56的71〜77位表示的氨基酸序列)和轻链CDR3(SEQ ID NO: :56)。
摘要:
An image forming apparatus includes a latent image carrier; a latent image writer to write a latent image on the latent image carrier; a developing unit including a toner carrier having first and second electrodes insulated via an insulator member and a voltage applying unit to apply voltages to the first and second electrodes having a potential difference to generate first electric fields to cause the toner to hop from the toner carrier to the latent image carrier to develop a toner image; and a transfer unit to transfer the developed toner image to a transferring member. When alternating voltages having a same phase and same amplitude are applied to the first and second electrodes to form second electric fields between the latent image carrier and the toner carrier, the toner is discharged from the toner carrier to the latent image carrier in a toner discharge mode.
摘要:
Disclosed is a convenient and effective means for quantifying an antigen-specific canine or human IgE. Specifically disclosed is a method for quantifying an antigen-specific canine IgE, which comprises the following steps (A) to (D): (A) contacting a biological sample collected from a subject with an antigen to conjugate IgE contained in the sample with the antigen; (B) measuring the quantity of IgE in a standard sample collected from an experimental animal which is different from the subject and has been sensitized with the same antigen as that used in step (A) by using a substance capable of recognizing both IgE from the subject and IgE from the experimental animal, thereby producing a standard curve; (C) detecting a conjugate formed in step (A) by using the same substance capable of recognizing both IgE from the subject and IgE from the experimental animal as that used in step (B); and (D) determining the quantity of IgE in the biological sample collected from the subject by utilizing the quantity of the conjugate detected in step (C) and the standard curve produced in step (B). Also specifically disclosed is a method for quantifying an antigen-specific human IgE.
摘要:
A development device includes a developer bearer to carry by rotation developer to a development range facing a latent image bearer, and a developer regulator to adjust an amount of developer transported to the development range by the developer bearer. Multiple projections are formed in a surface of the developer bearer, and the developer bearer rotates in a reverse direction to a direction of rotation for image development while image development is not performed. The developer regulator includes a blade having a first end held by a regulator holder and a second end that contacts the multiple projections formed in the surface of the developer bearer and is disposed in a direction counter to the direction of rotation of the developer bearer for image development.
摘要:
Disclosed is a convenient and effective means for quantifying an antigen-specific canine or human IgE. Specifically disclosed is a method for quantifying an antigen-specific canine IgE, which comprises the following steps (A) to (D): (A) contacting a biological sample collected from a subject with an antigen to conjugate IgE contained in the sample with the antigen; (B) measuring the quantity of IgE in a standard sample collected from an experimental animal which is different from the subject and has been sensitized with the same antigen as that used in step (A) by using a substance capable of recognizing both IgE from the subject and IgE from the experimental animal, thereby producing a standard curve; (C) detecting a conjugate formed in step (A) by using the same substance capable of recognizing both IgE from the subject and IgE from the experimental animal as that used in step (B); and (D) determining the quantity of IgE in the biological sample collected from the subject by utilizing the quantity of the conjugate detected in step (C) and the standard curve produced in step (B). Also specifically disclosed is a method for quantifying an antigen-specific human IgE.
摘要:
A development device provided with a first electrode layer and a second electrode layer, which are laminated so as to overlap one another in a normal direction with respect to the surface of the roller part of the toner bearing roller. A plurality of openings are provided in the second electrode layer, over the entire latent image bearable area of a photosensitive body in the orthogonal-to-movement direction. The toner on the surface of the roller part is caused to hop between a plurality of spots directly beneath the openings that respectively exist directly beneath the plurality of openings in the second electrode layer, and a plurality of spots between the openings that respectively exist between the plurality of openings in the second electrode layer, within the entire area of the first electrode layer which is uniformly formed in the roller circumferential direction.
摘要:
A disclosed development device includes: a latent image carrier; a conveying member disposed so as to face the latent image carrier, the conveying member having plural electrodes insulated from one another and arranged at predetermined intervals so as to generate an electric field for moving toner on the conveying member; a voltage application unit applying a voltage of n phases (n is a positive integer not less than one) to the electrodes so as to form a cloud of the toner and the toner is adhered to the latent image carrier so as to form a visualized toner image; a toner supply unit supplying the toner to the conveying member; and a height adjusting member adjusting a uniform height for a toner layer of the toner immediately before a development area on the conveying member in which development is performed.